Ellsworth Advisors, LLC Edwards Lifesciences Corp Transaction History

Ellsworth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$101.96 - $128.34 $3.48 Million - $4.38 Million	-34,138 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$106.37 - $130.68 $171,893 - $211,178	1,616 Added 4.97%	34,138 $4.42 Million
Q3 2021 Oct 18, 2021	BUY	$102.91 - $122.75 $521,239 - $621,728	5,065 Added 18.45%	32,522 $3.68 Million
Q2 2021 Jul 19, 2021	BUY	$83.84 - $104.76 $256,969 - $321,089	3,065 Added 12.57%	27,457 $2.84 Million
Q1 2021 Apr 21, 2021	BUY	$78.68 - $90.67 $161,608 - $186,236	2,054 Added 9.2%	24,392 $2.04 Million
Q4 2020 Feb 03, 2021	BUY	$71.69 - $91.23 $191,197 - $243,310	2,667 Added 13.56%	22,338 $2.04 Million
Q3 2020 Feb 03, 2021	SELL	$67.19 - $87.44 $2,486 - $3,235	-37 Reduced 0.19%	19,671 $1.57 Million
Q2 2020 Feb 03, 2021	BUY	$57.54 - $76.95 $1.13 Million - $1.52 Million	19,708 New	19,708 $1.36 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.